These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27813398)

  • 81. Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis.
    Palacios S; Kalouche-Khalil L; Rizzoli R; Zapalowski C; Resch H; Adachi JD; Gallagher JC; Feldman RG; Kendler DL; Wang A; Wagman RB; Adami S
    Climacteric; 2015; 18(6):805-12. PubMed ID: 26029985
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Evaluation of the efficacy and tolerability of alendronate versus denosumab in kidney transplant patients with reduced bone mineral density.
    Sayed SA; El Wakeel LM; Elseasi AM; Shawki MA
    Pharmacotherapy; 2023 Sep; 43(9):904-912. PubMed ID: 37323099
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis.
    Rajput S; Dutta A; Rajender S; Mithal A; Chattopadhyay N
    Front Endocrinol (Lausanne); 2023; 14():1098841. PubMed ID: 36817591
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Comparison of Denosumab and Bisphosphonates in Patients With Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.
    Lyu H; Jundi B; Xu C; Tedeschi SK; Yoshida K; Zhao S; Nigwekar SU; Leder BZ; Solomon DH
    J Clin Endocrinol Metab; 2019 May; 104(5):1753-1765. PubMed ID: 30535289
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Efficacy of denosumab co-administered with vitamin D and Ca by baseline vitamin D status.
    Sugimoto T; Matsumoto T; Hosoi T; Shiraki M; Kobayashi M; Okubo N; Takami H; Nakamura T
    J Bone Miner Metab; 2020 Nov; 38(6):848-858. PubMed ID: 32671481
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Follow-Up of Bone Mineral Density Changes in de novo Kidney Transplant Recipients Treated with Two Doses of the Receptor Activator of Nuclear Factor κB Ligand Inhibitor Denosumab.
    Kobel C; Frey D; Graf N; Wüthrich RP; Bonani M
    Kidney Blood Press Res; 2019; 44(5):1285-1293. PubMed ID: 31614356
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Significant improvement of bone mineral density by denosumab without bisphosphonate pre-treatment in glucocorticoid-induced osteoporosis.
    Suzuki T; Nakamura Y; Kato H
    Mod Rheumatol; 2018 Sep; 28(5):885-889. PubMed ID: 29251033
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effects of Denosumab and Alendronate on Bone Health and Vascular Function in Hemodialysis Patients: A Randomized, Controlled Trial.
    Iseri K; Watanabe M; Yoshikawa H; Mitsui H; Endo T; Yamamoto Y; Iyoda M; Ryu K; Inaba T; Shibata T
    J Bone Miner Res; 2019 Jun; 34(6):1014-1024. PubMed ID: 30690785
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Bone-modifying agents for bone loss in patients with prostate cancer receiving androgen deprivation therapy; insights from a network meta-analysis.
    Miyashita H; Satoi S; Cruz C; Kim SM; Patel VG
    Support Care Cancer; 2022 Jan; 30(1):855-863. PubMed ID: 34392414
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Determination of serum bone-related minerals during denosumab treatment in osteoporosis patients with rheumatoid arthritis: Mineral change by denosumab in osteoporosis with rheumatoid arthritis.
    Suzuki T; Nakamura Y; Kato H
    Clin Nutr ESPEN; 2018 Aug; 26():53-56. PubMed ID: 29908683
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Changes of Bone-Related Minerals during Denosumab Administration in Post-Menopausal Osteoporotic Patients.
    Suzuki T; Nakamura Y; Kato H
    Nutrients; 2017 Aug; 9(8):. PubMed ID: 28805705
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series.
    Orsolini G; Gavioli I; Tripi G; Viapiana O; Gatti D; Idolazzi L; Zanotti R; Rossini M
    Calcif Tissue Int; 2017 Jun; 100(6):595-598. PubMed ID: 28229176
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparison of the efficacy of denosumab and bisphosphonates for treating secondary osteoporosis in patients with rheumatoid arthritis.
    Kinoshita H; Miyakoshi N; Kashiwagura T; Kasukawa Y; Sugimura Y; Shimada Y
    Mod Rheumatol; 2017 Jul; 27(4):582-586. PubMed ID: 27659808
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial.
    Pawade TA; Doris MK; Bing R; White AC; Forsyth L; Evans E; Graham C; Williams MC; van Beek EJR; Fletcher A; Adamson PD; Andrews JPM; Cartlidge TRG; Jenkins WSA; Syed M; Fujisawa T; Lucatelli C; Fraser W; Ralston SH; Boon N; Prendergast B; Newby DE; Dweck MR
    Circulation; 2021 Jun; 143(25):2418-2427. PubMed ID: 33913339
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A Secondary Analysis of a Phase 3 Randomized Controlled Trial.
    Roy S; Malone S; Sun Y; Zaorsky NG; Spratt DE; Morgan SC; Dess RT; Wallis CJD; Kishan AU; Citrin DE; Saad F
    Int J Radiat Oncol Biol Phys; 2024 May; 119(1):119-126. PubMed ID: 37924987
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Is there a potential dual effect of denosumab for treatment of osteoporosis and sarcopenia?
    Miedany YE; Gaafary ME; Toth M; Hegazi MO; Aroussy NE; Hassan W; Almedany S; Nasr A; Bahlas S; Galal S;
    Clin Rheumatol; 2021 Oct; 40(10):4225-4232. PubMed ID: 34008069
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The clinical utility of TRACP-5b to monitor anti-resorptive treatments of osteoporosis.
    Gossiel F; Ugur A; Peel NFA; Walsh JS; Eastell R
    Osteoporos Int; 2022 Jun; 33(6):1357-1363. PubMed ID: 35102444
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Vitamin D and Calcium Are Required during Denosumab Treatment in Osteoporosis with Rheumatoid Arthritis.
    Nakamura Y; Suzuki T; Yoshida T; Yamazaki H; Kato H
    Nutrients; 2017 Apr; 9(5):. PubMed ID: 28445420
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Real World Experience of Denosumab Treatment in the Belfast Osteoporosis Service.
    Moran CP; English S; Beringer T; Lindsay JR
    Ulster Med J; 2019 Sep; 88(3):150-156. PubMed ID: 31619848
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus: A Danish Retrospective Cohort Study.
    Viggers R; Al-Mashhadi Z; Starup-Linde J; Vestergaard P
    Front Endocrinol (Lausanne); 2021; 12():826997. PubMed ID: 35154013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.